Rated 2.8 / 5 (How Ratings Work)
Possible to probable range of efficacy of cannabis for treatment of epilepsy.
Based on 36 Studies from 1980 - 2018
Study Name, Description & Year
Rating
Cannabidiol Regulates Long Term Potentiation Following Status Epilepticus: Mediation By Calcium Stores And Serotonin
Animal study (mice) — 2018
Report From A Survey Of Parents Regarding The Use Of Cannabidiol (Medicinal Cannabis) In Mexican Children With Refractory Epilepsy
A survey of 53 parents whose children suffered from refractory epilepsy. — 2017
Neurological Aspects Of Medical Use Of Cannabidiol
Review/Meta-Analysis — 2017
Protective Effects Of Cannabidiol Against Seizures And Neuronal Death In A Rat Model Of Mesial Temporal Lobe Epilepsy
Animal study (rats) — 2017
Assessing The Role Of Serotonergic Receptors In Cannabidiol's Anticonvulsant Efficacy
Animal study (mice) — 2017
Interactions Between Cannabidiol And Commonly Used Antiepileptic Drugs
In 39 adults and 42 children, CBD dose was started at 5 mg/kg/day and increased every 2 weeks by 5 mg/kg/day up to a maximum of 50 mg/kg/day. — 2017
Cannabidiol Attenuates Seizures And Social Deficits In A Mouse Model Of Dravet Syndrome
Animal study (mice) — 2017
Could Cannabidiol Be A Treatment Option For Intractable Childhood And Adolescent Epilepsy?
Review — 2017
Quality Of Life In Childhood Epilepsy In Pediatric Patients Enrolled In A Prospective, Open-label Clinical Study With Cannabidiol
A survey conducted on 48 caregivers of pediatric patients suffering form treatment-resistant epilepsy. — 2017
CBD-enriched Medical Cannabis For Intractable Pediatric Epilepsy: The Current Israeli Experience
Human trial conducted on 74 pediatric children with intractable epilepsy resistant to >7 antiepileptic drugs. — 2016
Plant-Derived And Endogenous Cannabinoids In Epilepsy
Review — 2016
ENDOCANNABINOID SYSTEM: A Multi-facet Therapeutic Target
Review — 2016
The Cannabinoid Receptor Agonist WIN55.212 Reduces Consequences Of Status Epilepticus In Rats
Animal study (rats) — 2016
Δ9-THC Intoxication By Cannabidiol-Enriched Cannabis Extract In Two Children With Refractory Epilepsy: Full Remission After Switching To Purified Cannabidiol
Case study conducted on two children with treatment-resistant epilepsy. — 2016
Marijuana Use In Adults Admitted To A Canadian Epilepsy Monitoring Unit.
292 patients with epilepsy. — 2016
Cannabidiol As A Potential Treatment For Febrile Infection-Related Epilepsy Syndrome (FIRES) In The Acute And Chronic Phases
A case study conducted on seven pediatric patients with FIRES. — 2016
Involvement Of TRPV1 Channels In The Activity Of The Cannabinoid WIN 55,212-2 In An Acute Rat Model Of Temporal Lobe Epilepsy
Animal study (rats) — 2016
Anticonvulsant Activity Of β-caryophyllene Against Pentylenetetrazol-induced Seizures.
Animal study (mice) — 2016
Cannabidiol In Patients With Treatment-resistant Epilepsy: An Open-label Interventional Trial
214 patients with severe treatment-resistant epilepsy. — 2016
Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors And Activates Hippocampal Cell Autophagy Pathway Along With Antioxidant Defense In Chronic Phase Of Pilocarpine-Induced Seizure
Animal study (rats) — 2016
Aberrant Epilepsy-associated Mutant Nav1.6 Sodium Channel Activity Can Be Targeted With Cannabidiol
Laboratory Study — 2016
Perceived Efficacy Of Cannabidiol-enriched Cannabis Extracts For Treatment Of Pediatric Epilepsy: A Potential Role For Infantile Spasms And Lennox-Gastaut Syndrome (LGS)
Parental survey conducted on 117 pediatric patients with epilepsy (including 53 with infantile spasms and LGS. — 2015
Drug–drug Interaction Between Clobazam And Cannabidiol In Children With Refractory Epilepsy.
A human trial conducted on 13 children with refractory epilepsy concomitantly taking clobazam and CBD. — 2015
Voltage-gated Sodium (NaV) Channel Blockade By Plant Cannabinoids Does Not Confer Anticonvulsant Effects Per Se
Animal study (rats) — 2014
Efficacy And Safety Of Epidiolex (Cannabidiol) In Children And Young Adults With Treatment-Resistant Epilepsy: Initial Data From An Expanded Access Program.
Human trial conducted on pediatric patients with treatment resistant epilepsy. — 2014
Cannabidiol Displays Antiepileptiform And Antiseizure Properties In Vitro And In Vivo
Animal study (mice) — 2009
Cerebrospinal Fluid Levels Of The Endocannabinoid Anandamide Are Reduced In Patients With Untreated Newly Diagnosed Temporal Lobe Epilepsy
Human patients with epilepsy — 2009
Temporal Characterization Of Changes In Hippocampal Cannabinoid CB(1) Receptor Expression Following Pilocarpine-induced Status Epilepticus
Animal study (epileptic rats) — 2009
Treatment With CBD In Oily Solution Of Drug-resistant Paediatric Epilepsies
18 children suffering from epileptic seizures who had no success with traditional pharmaceutical anti-seizure medications — 2005
Endocannabinoids And Their Implications For Epilepsy
Review — 2004
Experiences With THC-treatment In Children And Adolescents
No description — 2003
Anticonvulsant Activity Of N-Palmitoylethanolamide, A Putative Endocannabinoid, In Mice
Animal study (mice) — 2001
Chronic Administration Of Cannabidiol To Healthy Volunteers And Epileptic Patients
Double-blind placebo controlled trial conducted on 15 patients suffering from epilepsy — 1980